Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | GVAX |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
GVAX is a cancer vaccine derived from irradiated autologous or allogeneic tumor cells engineered to secrete GM-CSF, which potentially stimulates anti-tumor immune response (PMID: 16026242). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| AGEN2373 + Balstilimab + Cyclophosphamide + GVAX | AGEN2373 Balstilimab Cyclophosphamide GVAX | 0 | 1 |
| Busulfan + Fludarabine + GVAX + Methotrexate + Tacrolimus | Busulfan Fludarabine GVAX Methotrexate Tacrolimus | 0 | 1 |
| GVAX | GVAX | 0 | 0 |
| GVAX + Ipilimumab + Nivolumab | GVAX Ipilimumab Nivolumab | 0 | 1 |
| GVAX + unspecified PD-1 antibody | GVAX unspecified PD-1 antibody | 0 | 0 |